瑞邦药业 (834672.OC)

+ 收藏

现金流量表(瑞邦药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 90,322,826.71166,898,159.2585,689,489.33174,248,683.6675,698,664.50
 收到的税费返还(元) 10,666.421,086,167.72497,807.262,723,350.071,036,349.18
 收到其他与经营活动有关的现金(元) 1,065,946.011,231,175.941,120,123.691,370,539.38112,502.76
 经营活动现金流入小计(元) 91,399,439.14169,215,502.9187,307,420.28178,342,573.1176,847,516.44
 购买商品、接受劳务支付的现金(元) 52,161,208.48100,362,734.3560,792,012.4989,557,378.6337,944,552.05
 支付给职工以及为职工支付的现金(元) 22,243,086.6242,359,453.6922,617,258.1539,310,498.5419,303,628.84
 支付的各项税费(元) 4,060,059.806,430,654.334,587,783.067,174,271.203,371,248.88
 支付其他与经营活动有关的现金(元) 11,899,634.2917,548,278.136,463,247.8223,737,886.2911,935,111.81
 经营活动现金流出小计(元) 90,363,989.19166,701,120.5094,460,301.52159,780,034.6672,554,541.58
 经营活动产生的现金流量净额(元) 1,035,449.952,514,382.41-7,152,881.2418,562,538.454,292,974.86
二、投资活动产生的现金流量
 收回投资收到的现金(元) -14,123,929.7212,000,000.0066,585,740.0038,000,000.00
 取得投资收益收到的现金(元) 5,144.701,413,413.08430,731.83205,051.9944,361.73
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---53,595.00-
 收到其他与投资活动有关的现金(元) ----151,900.36
 投资活动现金流入小计(元) 5,144.7015,537,342.8012,430,731.8366,844,386.9938,196,262.09
 购建固定资产、无形资产和其他长期资产支付的现金(元) 10,399,918.5612,014,140.2510,515,564.4112,831,414.127,210,160.51
 投资支付的现金(元) 9,923.6414,257,666.4410,000,000.0073,585,740.0043,000,000.00
 支付其他与投资活动有关的现金(元) --1,307,689.92-300,000.00
 投资活动现金流出小计(元) 10,409,842.2026,271,806.6921,823,254.3386,417,154.1250,510,160.51
 投资活动产生的现金流量净额(元) -10,404,697.50-10,734,463.89-9,392,522.50-19,572,767.13-12,313,898.42
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 46,004,448.00100,382,921.0064,000,000.0081,000,000.0037,000,000.00
 收到其他与筹资活动有关的现金(元) 5,250,000.009,000,000.0035,100,000.0031,906,250.0010,000,000.00
 筹资活动现金流入小计(元) 51,254,448.00109,382,921.0099,100,000.00112,906,250.0047,000,000.00
 偿还债务支付的现金(元) 21,382,921.0077,780,000.0039,000,000.0095,658,700.0033,369,300.00
 分配股利、利润或偿付利息支付的现金(元) 14,522,293.0715,146,026.7814,505,804.1916,150,396.1514,342,619.76
 支付其他与筹资活动有关的现金(元) 2,074,000.005,457,000.0010,000,000.009,342,000.00-
 筹资活动现金流出小计(元) 37,979,214.0798,383,026.7863,505,804.19121,151,096.1547,711,919.76
 筹资活动产生的现金流量净额(元) 13,275,233.9310,999,894.2235,594,195.81-8,244,846.15-711,919.76
四、汇率变动对现金及现金等价物的影响(元) 365,551.38103,809.28281,159.53580,959.5255,561.19
五、现金及现金等价物净增加额(元) 4,271,537.762,883,622.0219,329,951.60-8,674,115.31-8,677,282.13
 加:期初现金及现金等价物余额(元) 9,499,408.656,615,786.636,615,786.6315,289,901.9415,289,901.94
 期末现金及现金等价物余额(元) 13,770,946.419,499,408.6525,945,738.236,615,786.636,612,619.81
补充资料:
 净利润(元) 10,294,515.3416,100,834.6912,299,548.1316,297,250.6812,747,161.50
 资产减值准备(元) -852,524.19-248,424.61-
 固定资产和投资性房地产折旧(元) 5,278,253.819,733,802.124,724,235.419,504,525.334,694,739.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 5,278,253.819,733,802.124,724,235.419,504,525.334,694,739.56
 无形资产摊销(元) 594,543.991,262,153.92624,598.96719,638.15359,819.08
 长期待摊费用摊销(元) 237,254.82366,104.09124,846.84236,416.32107,168.16
 处置固定资产、无形资产和其他长期资产的损失(元) ----85,036.88-
 固定资产报废损失(元) ---413,275.98-
 公允价值变动损失(元) -8,470.00-60,420.081,401,569.64222,469.64
 财务费用(元) 406,546.091,139,129.40452,603.45809,434.901,186,868.59
 投资损失(元) -5,144.70-657,132.92-430,731.83-139,111.63-44,361.73
 递延所得税(元) -547,172.66-374,644.36147,850.52-720,879.52-176,087.13
  其中:递延所得税资产减少(元) -555,382.92-377,173.77147,850.52-720,879.52-176,087.13
 递延所得税负债增加(元) 8,210.262,529.41---
 存货的减少(元) 11,079,048.52-16,835,444.78-6,039,404.33-9,540,487.37-74,814.95
 经营性应收项目的减少(元) -15,997,889.317,257,309.5016,653,811.701,274,574.3217,057,242.56
 经营性应付项目的增加(元) -10,574,692.18-16,412,290.70-35,538,784.98-2,124,733.45-32,031,388.32
 不涉及现金收支的投资和筹资活动金额其他项目(元) -789,988.32---
 现金的期末余额(元) 13,770,946.419,499,408.6525,945,738.236,615,786.636,612,619.81
 减:现金的期初余额(元) 9,499,408.656,615,786.636,615,786.6315,289,901.9415,289,901.94
 现金及现金等价物的净增加额(元) 4,271,537.762,883,622.0219,329,951.60-8,674,115.31-8,677,282.13
公告日期 2024-08-282024-04-292023-08-292023-04-272022-08-30
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院